Ingredion Analyst Price Targets - Benzinga

Ingredion Inc

INGRNYSE

Trade with Public

Trade with Public

$95.43

N/A

Últ. Act.: Oct 26, 4:00 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Ingredion Analyst Price Targets - Benzinga

Ingredion Analyst Price Targets

Wall Street analyst price targets and consensus rating for Ingredion (INGR).

Price Target Range — 13 Quarters

Analyst Consensus — 4 Analysts

2Buy

2Hold

Consensus RatingEqual-Weight# Analysts4Avg. Consensus PT$129Upside to Avg. PT+34.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	Barclays	Benjamin Theurer	PT Cut	Equal-Weight	$118→$115
Oct 5, 2026	UBS	Joshua Spector	PT Cut	Neutral	$108→$104
Aug 5, 2026	UBS	Joshua Spector	PT Raise	Neutral	$104→$108
Aug 5, 2026	Barclays	Benjamin Theurer	PT Cut	Equal-Weight	$120→$118
Jun 9, 2026	Oppenheimer	Kristen Owen	Downgrade	Outperform→Perform	—
May 6, 2026	Barclays	Benjamin Theurer	PT Cut	Equal-Weight	$128→$120
Apr 22, 2026	Oppenheimer	Kristen Owen	PT Cut	Outperform	$130→$126
Apr 9, 2026	UBS	Joshua Spector	PT Cut	Neutral	$124→$122
Mar 17, 2026	Benchmark	Ben Klieve	Initiate	Buy	$130
Feb 5, 2026	UBS	Joshua Spector	PT Raise	Neutral	$119→$124
Feb 4, 2026	Barclays	Benjamin Theurer	PT Raise	Equal-Weight	$124→$128
Feb 4, 2026	Stephens & Co.	Pooran Sharma	Maintained	Equal-Weight	$120
Nov 6, 2025	Barclays	Benjamin Theurer	Downgrade	Overweight→Equal-Weight	$168→$124
Nov 5, 2025	UBS	Joshua Spector	PT Cut	Neutral	$130→$119
Nov 5, 2025	Stephens & Co.	Pooran Sharma	PT Cut	Equal-Weight	$140→$120
Nov 5, 2025	BMO Capital	Andrew Strelzik	PT Cut	Market Perform	$143→$123
Oct 6, 2025	UBS	Joshua Spector	PT Cut	Neutral	$144→$130
Jul 9, 2025	UBS	Cody Ross	PT Raise	Neutral	$149→$151
Apr 22, 2025	Oppenheimer	Kristen Owen	PT Cut	Outperform	$167→$155
Apr 7, 2025	UBS	Cody Ross	Downgrade	Buy→Neutral	$165→$145

Analyst Ratings News

PRO
Barclays Maintains Equal-Weight on Ingredion, Lowers Price Target to $115

Barclays analyst Benjamin Theurer maintains Ingredion (NYSE:INGR) with a Equal-Weight and lowers the price target from $118 to $115.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Ingredion, Lowers Price Target to $104

UBS analyst Joshua Spector maintains Ingredion (NYSE:INGR) with a Neutral and lowers the price target from $108 to $104.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Ingredion, Raises Price Target to $108

UBS analyst Joshua Spector maintains Ingredion (NYSE:INGR) with a Neutral and raises the price target from $104 to $108.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Ingredion, Lowers Price Target to $118

Barclays analyst Benjamin Theurer maintains Ingredion (NYSE:INGR) with a Equal-Weight and lowers the price target from $120 to $118.

Benzinga Newsdesk

This Ingredion Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Analysts have mixed views on INGR stock.

Avi Kapoor

PRO
Oppenheimer Downgrades Ingredion to Perform

Oppenheimer analyst Kristen Owen downgrades Ingredion (NYSE:INGR) from Outperform to Perform.

Benzinga Newsdesk